Moreover, IDO inhibition shows synergistic effects on tumor cytotoxicity with immune checkpoint inhibitors (Table 2), such as PD-1/PD-L1 blockade and CTLA-4 blockade [327–329], and similar synergistic effects were also reported for chemotherapy [330-332] and radiotherapy [333]. This evidence concerns the gene CD274 and neoplasm.